Table 1 Participant Demographics.

From: Two-year long-term follow-up of treatment with the Optilume BPH catheter system in a randomized controlled trial for benign prostatic hyperplasia (The PINNACLE Study)

Characteristic

Optilume BPH

(n = 100)

Age (years)

64.5 ± 6.4

BMI (kg/m2)

29.3 ± 4.5

Prostate Specific Antigen (ng/mL)

2.42 ± 2.0

Prostate Volume (mL)

44.9 ± 14.53

Intravesical Prostatic Protrusion

28.0% (28/100)

    IPP Size (mm)

    5.1 ± 2.2

IPSS Score

23.4 ± 5.5

Qmax (mL/sec)

8.9 ± 2.2

Post-Void Residual Volume (mL)

84.1 ± 70.2

Back to article page